March 30, 2026 · Form 4 insider transaction
Dandekar Atul sold 790 shares of Maze Therapeutics, Inc. at $30.02 per share, a transaction worth $23.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.87 to $30.24 per share, inclusive.